VDR (vitamin D receptor; HGNC:12679, NCBI Gene 7421) is the gene on chromosome 12q13.11 encoding the vitamin-D receptor — the nuclear receptor that 1,25-dihydroxy-vitamin D binds to regulate calcium-homeostasis genes (CYP24A1, TRPV6, calbindin) across gut, kidney, and bone, with immune-cell and proliferation-control roles beyond. Hereditary vitamin-D-resistant rickets follows loss-of-function; VDR polymorphisms populate the association literature from bone density to bowel disease.
Approved Symbol
VDR (HGNC:12679)
Chromosomal Locus
12q13.11
Encoded Product
VDR — a 48-kDa nuclear receptor (427 aa) heterodimerizing with RXR
Hereditary vitamin-D-resistant rickets; bone-density and IBD association genetics
Gene Structure & Expression
Genomic organization: 11 exons with multiple promoters; the DNA-binding C domain and ligand-binding E domain — the FokI polymorphism generating a shorter (more active) receptor among the studied variants.
Expression: Gut, kidney, and bone (the calcium axis), plus immune cells (monocytes, dendritic cells' tolerogenic programming) and skin — vitamin-D biology's reach.
Molecular Function & Pathways
The calcium program: Calcitriol-bound VDR (with RXR — the RXRA partner) inducing TRPV6 and calbindin in gut (calcium absorption) and CYP24A1 (the degradation feedback) — the axis detailed on the vitamin-D nutrient page.
Beyond calcium: Antimicrobial-peptide (cathelicidin) induction in macrophages; dendritic-cell tolerogenesis; and keratinocyte differentiation — the extraskeletal biology that made vitamin-D measurement a clinical industry — extraskeletal roles whose intervention trials have largely tempered the candidate-era enthusiasm — the VDR-null mouse's rickets rescued by calcium alone being the field's cautionary classic.
Clinical & Therapeutic Significance
Clinical genetics: Hereditary vitamin-D-resistant rickets (recessive VDR loss — alopecia marking the receptor's skin role); hypocalcemic-rickets discrimination from CYP27B1 defects.
Association genetics: VDR-FokI/TaqI/Apal variants in bone-density, fracture, and colorectal-cancer-risk studies (mostly small effects) — the GWAS-era lesson about candidate-gene literature.